The Chocolate Touch Study
Public ClinicalTrials.gov record NCT02924857. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Trial to Confirm the Safety and Effectiveness of Chocolate Touch™ Paclitaxel Coated Balloon Catheter, in Above the Knee Lesions
Study identification
- NCT ID
- NCT02924857
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- TriReme Medical, LLC
- Industry
- Enrollment
- 333 participants
Conditions and interventions
Interventions
- Chocolate Touch Device
- Lutonix Drug Coated Balloon Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2017
- Primary completion
- May 31, 2025
- Completion
- Nov 30, 2026
- Last update posted
- Oct 29, 2023
2017 – 2026
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiac and Vascular Institute | Gainesville | Florida | 32605 | — |
| Mt. Sinai - Miami | Miami Beach | Florida | 33140 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Cardiovascular Institute of the South | Houma | Louisiana | 70360 | — |
| Michigan Outpaitient Vascular Institution | Dearborn | Michigan | 48126 | — |
| Jackson Heart | Jackson | Mississippi | 39216 | — |
| St. Luke's Hospital | Kansas City | Missouri | 64111 | — |
| Mt. Sinai Heart | New York | New York | 10029 | — |
| Columbia University Medical Center / NewYork Presbyterian Hospital | New York | New York | 10032 | — |
| Univeristy Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Penn State Health Holy Spirit Medical Center | Camp Hill | Pennsylvania | 17011 | — |
| Pinnacle Health Cardiovascular Institute | Wormleysburg | Pennsylvania | 17043 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| MIssion Research | New Braunfels | Texas | 78130 | — |
| Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02924857, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 29, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02924857 live on ClinicalTrials.gov.